Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 09/20/2002
Publisher: CLSI
File Format: PDF
$120.00$240.61
Published:20/09/2002
Pages:56
CLSI EP09-A2 addresses procedures for determining the bias between two clinical methods or devices, and for the design of a method comparison experiment using split patient samples and data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guidleine for use in satisfying a regulatory requirement.
Analytical Procedures for the Determination of Lead in Blood and Urine; Approved Guideline, C40A2E
$90.00 $180.00
User Evaluation of Between-Reagent Lot Variation; Approved Guideline, EP26AE
Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline--Second Edition, MM07A2E
Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline--Third Edition, EP09A3E
$110.00 $220.02
